The human body is highly complex, and some medical discoveries happen by chance. One such example is the transformation of a drug originally intended to treat angina into a therapy for erectile dysfunction. Recent studies have once again drawn attention to the mechanism of this medication and revealed its potential new applications.

History and Mechanism of Action

The active ingredient in Viagra, sildenafil, was initially developed to lower blood pressure and treat chest pain associated with reduced blood flow to the heart. Since erections are directly linked to blood supply, a side effect of the drug led to its widespread use for treating erectile dysfunction.

Sildenafil works by blocking enzymes in the phosphodiesterase group (PDE5), which increases the level of cyclic guanosine monophosphate (cGMP). This substance dilates blood vessels and boosts blood flow to the corpora cavernosa of the penis. It has also been found that cGMP binds to a protein responsible for transporting cholesterol inside cells, reducing the amount of cholesterol available to cancer cells.

Impact on Cancer Metastasis

An international team of researchers discovered that sildenafil can slow the development of cancer metastases. A study published in the journal Cancer Research showed that the active component of Viagra hinders cancer cells from utilizing cholesterol. Cholesterol is essential for forming cell membranes and helps cancer cells detach from the primary tumor, spread throughout the body, and form secondary tumors. Limiting access to cholesterol reduces the likelihood of metastasis.

Combined Use with Other Drugs

It was also found that combining sildenafil with statins, well-known cholesterol-lowering drugs, further impedes tumor metastasis. Statins not only reduce cholesterol intake but also block its synthesis by cancer cells. The combined effect of these medications may have a synergistic benefit in cancer therapy.

Research Results

Experiments were conducted on human and mouse cells. Additionally, an analysis was performed using a database from an Israeli medical organization, which included information on five million patients over 20 years. The analysis showed that simultaneous use of statins and drugs for erectile dysfunction is associated with increased survival rates in patients with cancer.

Conclusions

This study highlights the importance of a comprehensive approach to patient treatment, taking into account not only genetic changes in tumor cells but also the overall metabolic state of the body and all medications being taken.